Abdellatif A G, Préat V, Taper H S, Roberfroid M
Unité de Biochimie Toxicologique et Cancérologique, Ecole de Pharmacie, Université Catholique de Louvain, Brussels, Belgium.
Toxicol Appl Pharmacol. 1991 Dec;111(3):530-7. doi: 10.1016/0041-008x(91)90257-f.
Perfluorooctanoic acid (PFOA) is a peroxisome proliferator. The aim of this study was to test for its ability to act as a positive modulator of hepatocarcinogenesis, in the so-called biphasic (initiation by diethylnitrosamine 200 mg/kg ip followed by treatment with the suspected modulators) and triphasic (initiation by the same dose of diethylnitrosamine followed by a selection procedure for 2 weeks consisting of giving 2-acetylaminofluorene and in the middle of this treatment a single dose of CCl4 followed by treatment with the suspected modulators) protocols of liver carcinogenesis. In both protocols treatment with PFOA increased the incidence of malignant hepatocellular carcinoma (HCC). As compared to phenobarbital, the modulating effect of PFOA is more pronounced in a biphasic than in the triphasic protocol. In parallel with positive modulation of HCC, PFOA also selectively induced the peroxisomal acyl-CoA oxidase activity and, to a lesser extent, catalase activity.
全氟辛酸(PFOA)是一种过氧化物酶体增殖剂。本研究的目的是测试其在所谓的双相(腹腔注射200mg/kg二乙基亚硝胺启动,随后用疑似调节剂处理)和三相(用相同剂量的二乙基亚硝胺启动,然后进行为期2周的筛选程序,包括给予2-乙酰氨基芴,在该处理过程中间给予单剂量四氯化碳,随后用疑似调节剂处理)肝癌发生方案中作为肝癌发生阳性调节剂的能力。在这两种方案中,用PFOA处理均增加了恶性肝细胞癌(HCC)的发生率。与苯巴比妥相比,PFOA在双相方案中的调节作用比在三相方案中更明显。与HCC的阳性调节同时,PFOA还选择性地诱导过氧化物酶体酰基辅酶A氧化酶活性,并在较小程度上诱导过氧化氢酶活性。